Related Experiment Video
Updated: Mar 5, 2026

Optimized Fibrin Gel Bead Assay for the Study of Angiogenesis
Published on: April 29, 2007
[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate]
Jennifer Howlett1, Christelle Prudent1, Emmanuel De Maistre2
1Service pharmacie, hôpital François-Mitterrand, 14, rue Gaffarel, 21000 Dijon, France.
Insights
Fibrinogen concentrate prescriptions increased after 2015 guidelines. Evaluation showed appropriate dosing in 73% of cases, but low fibrinogen levels were below recommended limits in 59%, questioning prescription necessity.
Area of Science:
- Hematology
- Clinical Pharmacy
- Medical Guidelines
Background:
- Fibrinogen concentrate prescriptions rose significantly in 2015 following new guideline publications.
- The study addresses the need to assess the appropriate utilization of fibrinogen concentrate post-guideline implementation.
Purpose of the Study:
- To evaluate the conformity of fibrinogen concentrate prescriptions with established clinical guidelines.
- To assess the appropriateness of prescribed dosages and patient outcomes.
Main Methods:
- Retrospective analysis of 202 prescriptions for 117 patients.
- Evaluation criteria included fibrinogen level measurement, adherence to recommended dosage thresholds, and posology conformity.
- Assessment of treatment efficacy and safety was also performed.
Main Results:
- Indications for prescription were met in all but one case.
- Blood fibrinogen levels were measured in 76% of prescriptions, with 59% below the recommended threshold for prescription.
- Prescription posology aligned with guidelines in 73% of cases; 20% were underdosed.
- Patients receiving lower doses appeared to have lower risk, raising questions about prescription necessity.
Conclusions:
- Guideline adherence for fibrinogen concentrate prescription varies, influenced by the urgency of the clinical situation.
- Further prospective studies are recommended to elucidate the reasons for prescribing doses below guideline recommendations.
Abstract:
An increase in fibrinogen concentrate prescriptions was noticed in 2015 after several guidelines regarding their use were published. We tried to evaluate if they were used appropriately. To evaluate the conformity of the prescriptions to these guidelines, we searched for each prescription if a dosage of blood fibrinogen was made, if its result was below the limit recommended to prescribe fibrinogen concentrate, and if the posology was in line with the recommendations. Effect and security of the treatment was also evaluated. We analyzed 202 prescriptions for 117 patients. The indications are respected except for one prescription for which we could not find it. The blood fibrinogen is measured for 76% of the prescriptions, 59% of the results are below the limit recommended to prescribe. The posology is conforming to the guidelines for 73% of the prescriptions, it is below the dose recommended for 20%. Patients who were prescribed low doses seemed less at risk than the others which questions the necessity of the prescriptions. The guidelines respect depends on the emergency of the prescription situation. It would be interesting to conduct a prospective study to better explain why doses below those recommended are prescribed.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

